Ingredient

GINSENOSIDE RD

✓ EU Allowed

Identification

CAS Number 52705-93-8
EINECS / EC 258-118-5
CosIng Ref 97223
Chemical Name (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
IUPAC Name —
Formula C48H82O18
Mol. Weight 947.2 g/mol
InChIKey RLDVZILFNVRJTL-IWFVLDDISA-N

Function & Classification

Primary Function ANTIOXIDANT

EU Regulatory Status

🇪🇺
✓ Allowed — EU Reg. 1223/2009

Safety Profile

No toxicology data available yet for this ingredient.

Check SCCS opinions or CIR reports for published safety assessments.

NOAEL · Dermal Absorption % · Sensitization

Formulation Guidelines

Usage level, pH range, solubility and addition phase not yet available.

Usage Level % · Addition Phase · Solubility

Suppliers & Documents

Log in to see suppliers.

Log in or register to see suppliers and documents for GINSENOSIDE RD.

Documents

External Resources